Roxicet

Product NDC: 0054-4650
11-digit product format: 000544650
Labeler code: 0054
Product ID: 0054-4650_287496b8-2d45-4949-8194-d540281c2532
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Oxycodone and Acetaminophen
Dosage form: TABLET
Route: ORAL
Labeler: West-Ward Pharmaceuticals Corp
Application: ANDA087003
Marketing category: ANDA
Marketing start: 1991-02-01
Marketing end: 0000-00-00
Substance: OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN
Active strength: 5 mg/1; mg/1
Pharmacologic classes: Full Opioid Agonists [MoA],Opioid Agonist [EPC]
DEA schedule: CII
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0054-4650		D	Discontinued by firm	2026-10-05
excluded package	package	0054-4650	0054-4650-25	D	Discontinued by firm	2026-10-05
excluded package	package	0054-4650	0054-4650-29	D	Discontinued by firm	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 45 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0054-4650-25	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0054-4650-29	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0054-4650-25	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0054-4650-29	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0054-4650-25	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0054-4650-29	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0054-4650-25	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0054-4650-29	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0054-4650-25	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0054-4650-29	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0054-4650-25	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0054-4650-29	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0054-4650-25	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0054-4650-29	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0054-4650-25	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0054-4650-29	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0054-4650-25	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0054-4650-29	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0054-4650-25	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0054-4650-29	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0054-4650-25	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0054-4650-29	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0054-4650-25	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0054-4650-29	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A087003-001	ROXICET	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325MG;5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Source SHA-256
2026-09-14 22:38:34	2026-08	A087003-001	ROXICET	325MG;5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD, Approved before 1982	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A087003-001	ROXICET	325MG;5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD, Approved before 1982	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A087003-001	ROXICET	325MG;5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD, Approved before 1982	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A087003-001	ROXICET	325MG;5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD, Approved before 1982	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL	AA	Approved before 1982	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		Approved before 1982	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		Approved before 1982	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL	AA	Approved before 1982	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL	AA	Approved before 1982	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL	AA	Approved before 1982	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL	AA	Approved before 1982	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL	AA	Approved before 1982	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A087003-001	ROXICET	325MG;5MG	TABLET / ORAL		RLD, Approved before 1982	`f41ea6bd6efb…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A087003-001	AA	1	`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	A087003-001	AA	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A087003-001	AA	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A087003-001	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A087003-001	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A087003-001	AA	1	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
0054-4650-25	2025-09-04	ROXICET™ CII Oxycodone 5 mg and Acetaminophen 325 mg Tablets, USP Oxycodone 5 mg and Acetaminophen 325 mg Oral Solution per 5 mL
0054-4650-29	2025-09-04	ROXICET™ CII Oxycodone 5 mg and Acetaminophen 325 mg Tablets, USP Oxycodone 5 mg and Acetaminophen 325 mg Oral Solution per 5 mL
0054-4650-25	2020-01-31	ROXICET™ CII Oxycodone 5 mg and Acetaminophen 325 mg Tablets, USP Oxycodone 5 mg and Acetaminophen 325 mg Oral Solution per 5 mL
0054-4650-29	2020-01-31	ROXICET™ CII Oxycodone 5 mg and Acetaminophen 325 mg Tablets, USP Oxycodone 5 mg and Acetaminophen 325 mg Oral Solution per 5 mL

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0054-4650-25	EA - Each	0054-4650	b5a2336b-c3e7-4ac8-9d9b-0d05d9c7367d	1	2012-07-24
0054-4650-29	EA - Each	0054-4650	8ce7026c-dee0-450a-a337-f8def6c1e9da	1	2013-02-11

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ACETAMINOPHEN	ACTIVE INGREDIENT	362O9ITL9D	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
OXYCODONE HYDROCHLORIDE	ACTIVE INGREDIENT	C1ENJ2TE6C	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
ACETAMINOPHEN	ACTIVE MOIETY	362O9ITL9D	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
OXYCODONE	ACTIVE MOIETY	CD35PMG570	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
FRUCTOSE	INACTIVE INGREDIENT	6YSS42VSEV	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
POTASSIUM SORBATE	INACTIVE INGREDIENT	1VPU26JZZ4	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13
WATER	INACTIVE INGREDIENT	059QF0KO0R	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [ROXANE LABORATORIES, INC.]	13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0054-4650	ROXICET (OXYCODONE AND ACETAMINOPHEN) TABLET ROXICET (OXYCODONE AND ACETAMINOPHEN) SOLUTION [WEST-WARD PHARMACEUTICALS CORP]	14	Legacy NDC	20160812_86817b05-450c-4af0-aeea-acba2ac00601.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
C1ENJ2TE6C	OXYCODONE HYDROCHLORIDE	124-90-3	OXYCODONE HYDROCHLORIDE
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Roxicet	West-Ward Pharmaceuticals Corp \| West-Ward Columbus Inc. \| Noramco Inc. (DE) \| Noramco Inc. (GA) \| Rhodia Wuxi Pharmaceutical Co., Ltd. \| Mallinckrodt Inc.	2016-08-12	HUMAN PRESCRIPTION DRUG LABEL	14